|
- NINLARO® For Relapsed Multiple Myeloma - Patient Information
Learn about the NINLARO® (ixazomib) treatment combination for multiple myeloma that has returned that may help you keep an active lifestyle See Important Safety Information and Prescribing Information
- How NINLARO® (ixazomib) Works For Relapsed Multiple Myeloma
Proteasome inhibitors are a proven foundation for myeloma treatment NINLARO is the first and only proteasome inhibitor that is taken orally NINLARO is taken as part of an all-oral treatment combination* NINLARO is not chemotherapy and does not require injections or infusions
- How to Take the NINLARO® (ixazomib) Treatment Combination
See step-by-step instructions for taking the NINLARO® (ixazomib) treatment combination Learn about the dosing schedule and resources to help you stay on treatment See Important Safety Information and Prescribing Information
- Potential Side Effects of NINLARO® (ixazomib)
Taking too much NINLARO (overdose) can cause serious side effects, including death If you take more NINLARO than instructed by your healthcare provider, call your healthcare provider right away or go to the nearest hospital emergency room right away Take your medicine pack with you
- Prescribing Information for NINLARO® (ixazomib)
NINLARO is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy
- What Is Multiple Myeloma? - NINLARO® (ixazomib)
What is NINLARO? NINLARO is a prescription medicine used to treat multiple myeloma in combination with the medicines REVLIMID ® (lenalidomide) and dexamethasone, in people who have received at least one prior treatment for their multiple myeloma
- Información de prescripción para NINLARO® (ixazomib)
NINLARO es un inhibidor de una proteasoma indicado en combinación con lenalidomide y dexametasona para el tratamiento de pacientes con mieloma múltiple que han recibido al menos una terapia previa
- PATIENT INFORMATION NINLARO
NINLARO is a prescription medicine used to treat multiple myeloma in combination with the medicines REVLIMID ® ( lenalidomide) and dexamethasone, in people who have received at least one prior treatment for
|
|
|